Company Filing History:
1 out of 12,160 
1 out of 1,209 
1 out of 443 
Years Active: 2025
Title: Alisha Caliman: Innovator in Pharmaceutical Development
Introduction
Alisha Caliman is a notable inventor based in Cambridge, MA, who has made significant contributions to the field of pharmaceuticals. With a focus on developing innovative compounds, she has been instrumental in advancing treatments for proliferative disorders.
Latest Patents
Alisha holds a patent for a compound known as 3-amino-2-[2-(acylamino)pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one, which serves as a Casein kinase 1 (CSNK1) inhibitor. This invention relates to the production processes of these compounds and their application as pharmaceuticals. The compounds are specifically designed to inhibit Casein kinase 1 alpha and/or delta (CSNK1α and/or β), which are useful in treating various proliferative disorders.
Career Highlights
Throughout her career, Alisha has worked with prominent organizations, including Bayer Aktiengesellschaft and Dana-Farber Cancer Institute Inc. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Alisha has collaborated with notable colleagues such as Volker Schulze and Anne Mengel, enhancing her work through shared expertise and innovative ideas.
Conclusion
Alisha Caliman's contributions to pharmaceutical innovation highlight her role as a key inventor in the development of treatments for proliferative disorders. Her work continues to impact the field positively, showcasing the importance of innovation in healthcare.